新型冠状病毒肺炎疫情下骨质疏松症管理专家建议

doi:10.16150/j.1671-2870.2022.02.005

诊断学理论与实践 ›› 2022, Vol. 21 ›› Issue (02): 133-135.doi: 10.16150/j.1671-2870.2022.02.005

新型冠状病毒肺炎疫情下骨质疏松症管理专家建议

中华医学会内分泌学分会

国家代谢性疾病临床医学研究中心（上海）

收稿日期:2022-05-27 出版日期:2022-05-30 发布日期:2022-04-25
通讯作者: 中华医学会内分泌学分会

Expert suggestion for osteoporosis management during the recent COVID-19 pandemic

Chinese Society of Endocrinology,Chinese Medical Association , et al

National Metabolic Diseases Clinical Research Center (Shanghai)

Received:2022-05-27 Online:2022-05-30 Published:2022-04-25
Contact: Chinese Society of Endocrinology,Chinese Medical Association

摘要/Abstract

摘要：

骨质疏松症是一种慢性疾病,表现为骨强度降低和骨折风险增加。骨质疏松症通常需要持续的医疗干预,以减少骨质丢失、骨骼完整性受损和骨折发生的风险。2019年新型冠状病毒（新冠）疾病大流行给全球医疗服务的提供带来了前所未有的破坏,包括抗骨质疏松治疗的停止可能会增加对骨骼的伤害风险。基于此,本专家意见为新冠疫情时期骨质疏松症患者的管理提供指导建议,以使患者能从疫情时期安全地过渡到常规管理。

关键词: 新型冠状病毒肺炎, 骨质疏松症, 骨质疏松性骨折, 抗骨质疏松治疗

Abstract:

Osteoporosis is a chronic condition that reflects reduced bone strength and increased risk for fracture. As a chronic disease, osteoporosis generally requires sustained medical intervention to reduce the risks for bone loss, impaired bone integrity and fractures. The coronavirus disease 2019(COVID-19) pandemic has brought the unprecedented harmful effects on medical service,such as the cessation of osteoporosis therapies might be associated with an increased harm for bone health. The present expert suggestion provides recommendation for the management of osteoporotic patient during COVID-19, to help them safely return to routine clinical management.

Key words: COVID-19, Osteoporosis, Osteoporotic fracture, Anti-osteoporosis medication

中图分类号:

R589.5

中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下骨质疏松症管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 133-135.

Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for osteoporosis management during the recent COVID-19 pandemic[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 133-135.

参考文献 12

[1]	Lv H, Zhang Q, Yin Y, et al. Epidemiologic characteristics of traumatic fractures during the outbreak of coronavirus disease 2019 (COVID-19) in China: A retrospective & comparative multi-center study[J]. Injury,2020, 51(8):1698-1704. doi: 10.1016/j.injury.2020.06.022 URL
[2]	中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华内分泌代谢杂志, 2017, 33(10):890-913.
	Osteoporosis and bone mineral Disease Branch of Chinese Medical Association. Diagnosis and treatment guidelines for primary osteoporosis(2017)[J]. Chin J Endocrinol Metab, 2017, 33(10):890-913.
[3]	Mitchell F. Vitamin-D and COVID-19: do deficient risk a poorer outcome?[J]. Lancet Diabetes Endocrinol, 2020, 8(7):570. doi: 10.1016/S2213-8587(20)30183-2 URL
[4]	中国营养学会骨营养与健康分会, 中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症患者的营养和运动管理专家共识[J]. 中华内分泌代谢杂志, 2020, 36(8):643-653.
	Bone nutrition and health branch of Chinese Nutrition Society, Osteoporosis and bone mineral Disease Branch of Chinese Medical Association. Expert consensus on nutrition and exercise management of patients with primary osteoporosis[J]. Chin J Endocrinol Metab, 2020, 36(8):643-653.
[5]	杨嫣琼, 张巧, 彭年春, 等. 睡眠时长、入睡时间与绝经后女性骨质疏松风险的相关性研究[J]. 中华内分泌代谢杂志, 2020, 36(11):949-955.
	Yang YQ, Zhang Q, Peng NC, et al. Study on the relationship between sleep duration, sleep time and the risk of osteoporosis in postmenopausal women[J]. Chin J Endocrinol Metab, 2020, 36(11):949-955.
[6]	Saag K, Lindsay R, Kriegman A, et al. A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density[J]. Bone, 2007, 40(5):1238-1243. doi: 10.1016/j.bone.2007.01.016 URL
[7]	Rossini M, Adami S, Viapiana O, et al. Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration[J]. J Bone Miner Res, 2012, 27(1):227-230. doi: 10.1002/jbmr.521 URL
[8]	Zhu FC, Li YH, Guan XH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial[J]. Lancet, 2020, 395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3 URL
[9]	Baden LR, El Sahly HM, Essink B, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine[J]. N Engl J Med, 2021, 384(5):403-416. doi: 10.1056/NEJMoa2035389 URL
[10]	Reid IR, Gamble GD, Mesenbrink P, et al. Characterization of and risk factors for the acute-phase response after zoledronic acid[J]. J Clin Endocrinol Metab, 2010, 95(9):4380-4387. doi: 10.1210/jc.2010-0597 pmid: 20554708
[11]	Blanch-Rubió J, Soldevila-Domenech N, Tío L, et al. Influence of anti-osteoporosis treatments on the incidence of COVID-19 in patients with non-inflammatory rheumatic conditions[J]. Aging (Albany NY), 2020, 12(20):19923-19937.
[12]	Bone HG, Wagman RB, Brandi ML, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension[J]. Lancet Diabetes Endocrinol, 2017, 5(7):513-523. doi: 10.1016/S2213-8587(17)30138-9 URL

[1]	石峰, 郭竹英, 郭海艳. 新型冠状病毒肺炎患者外周血淋巴细胞亚群变化的临床意义[J]. 诊断学理论与实践, 2022, 21(05): 619-624.
[2]	刘欣, 綦才辉, 王振竞, 吕娜, 王少婷, 王淑萍. 胰高血糖素样肽-1激动剂Exendin-4 刺激小鼠胚胎成骨细胞前体细胞MC3T3-E1的转录组学体外研究[J]. 诊断学理论与实践, 2022, 21(03): 367-373.
[3]	陈沁, 徐雯莉, 丰青, 陈瑜, 邓雪芹, 陈芸, 庞碧芸. 新型冠状病毒肺炎收治定点医院护理人力资源的调配与实践[J]. 诊断学理论与实践, 2022, 21(02): 273-276.
[4]	张红, 朱梦梦. 新型冠状病毒肺炎疫情期间老年人进食安全护理[J]. 诊断学理论与实践, 2022, 21(02): 277-280.
[5]	梁婧, 黄晨, 蒋琰, 许敬华, 梁晓虹, 杨之涛, 景峰. 新冠疫情下急诊输液室的护理防控管理策略[J]. 诊断学理论与实践, 2022, 21(02): 281-285.
[6]	新冠病毒定点医院公共学科工作模式撰写组. 上海交通大学医学院附属瑞金医院抗击新型冠状病毒定点医院公共学科工作模式[J]. 诊断学理论与实践, 2022, 21(02): 118-127.
[7]	中华医学会内分泌学分会. 新型冠状病毒肺炎疫情下肾上腺疾病管理专家建议[J]. 诊断学理论与实践, 2022, 21(02): 139-142.
[8]	陈长强, 孟俊, 金佩佩, 戴菁. 定点医院新型冠状病毒肺炎患者核酸检测工作的实践和探索[J]. 诊断学理论与实践, 2022, 21(02): 143-149.
[9]	施莺莺, 钟旭, 刘嘉琳, 何乐, 熊少洁, 翁懿, 丁成唯, 杨溢, 陈伟红, 邱力萍, 辛海光. 新型冠状病毒疫情相关防疫工作人员感染防控实践调查分析及对策[J]. 诊断学理论与实践, 2022, 21(02): 178-183.
[10]	蒋琰, 林薇, 黄晨, 景峰. 疫情下急诊科应急物资管理模式的探索与实践[J]. 诊断学理论与实践, 2022, 21(02): 212-215.
[11]	于平, 裘卫宇, 王旭, 张徐婧, 尚寒冰, 顾志冬, 林靖生, 景峰, 杨之涛, 毕宇芳, 陈尔真. 大型方舱医院药品保障管理的实践与探索[J]. 诊断学理论与实践, 2022, 21(02): 221-224.
[12]	万瑾, 林婧, 丁芸, 陆琳, 成杰. 特大型城市综合性医院疫情防控期间涉医电话咨询应对模式与实践[J]. 诊断学理论与实践, 2022, 21(02): 225-228.
[13]	查庆华, 王晓宁, 张寅, 倪雪萍, 陈燕, 朱唯一. 新型冠状病毒流行期间医院外核酸采样工作的探索与实践[J]. 诊断学理论与实践, 2022, 21(02): 229-233.
[14]	庄蕾, 高卫益. 新型冠状病毒肺炎疫情期间非定点医疗机构“分区管理”策略[J]. 诊断学理论与实践, 2022, 21(02): 245-247.
[15]	虞佩, 金瑞, 唐静, 陈海涛, 高卫益. 新型冠状病毒感染疫情期间非定点医疗机构急诊区域的管理策略[J]. 诊断学理论与实践, 2022, 21(02): 248-251.

新型冠状病毒肺炎疫情下骨质疏松症管理专家建议

Expert suggestion for osteoporosis management during the recent COVID-19 pandemic

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 12

相关文章 15

编辑推荐

Metrics

本文评价